369 related articles for article (PubMed ID: 28819685)
1. Cardiomyocyte dimethylarginine dimethylaminohydrolase-1 (DDAH1) plays an important role in attenuating ventricular hypertrophy and dysfunction.
Xu X; Zhang P; Kwak D; Fassett J; Yue W; Atzler D; Hu X; Liu X; Wang H; Lu Z; Guo H; Schwedhelm E; Böger RH; Chen P; Chen Y
Basic Res Cardiol; 2017 Aug; 112(5):55. PubMed ID: 28819685
[TBL] [Abstract][Full Text] [Related]
2. Cardiomyocyte dimethylarginine dimethylaminohydrolase1 attenuates left-ventricular remodeling after acute myocardial infarction: involvement in oxidative stress and apoptosis.
Hou L; Guo J; Xu F; Weng X; Yue W; Ge J
Basic Res Cardiol; 2018 Jun; 113(4):28. PubMed ID: 29892894
[TBL] [Abstract][Full Text] [Related]
3. Dimethylarginine dimethylaminohydrolase 1 deficiency aggravates monocrotaline-induced pulmonary oxidative stress, pulmonary arterial hypertension and right heart failure in rats.
Wang D; Li H; Weir EK; Xu Y; Xu D; Chen Y
Int J Cardiol; 2019 Nov; 295():14-20. PubMed ID: 31402164
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of dimethylarginine dimethylaminohydrolase 1 protects from angiotensin II-induced cardiac hypertrophy and vascular remodeling.
Kopaliani I; Jarzebska N; Billoff S; Kolouschek A; Martens-Lobenhoffer J; Bornstein SR; Bode-Böger SM; Ragavan VN; Weiss N; Mangoni AA; Deussen A; Rodionov RN
Am J Physiol Heart Circ Physiol; 2021 Nov; 321(5):H825-H838. PubMed ID: 34533401
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of low-dose rosuvastatin on isoproterenol-induced chronic heart failure in rats by regulation of DDAH-ADMA-NO pathway.
Zhou R; Ma P; Xiong A; Xu Y; Wang Y; Xu Q
Cardiovasc Ther; 2017 Apr; 35(2):. PubMed ID: 27957828
[TBL] [Abstract][Full Text] [Related]
6. BMP-7 attenuates left ventricular remodelling under pressure overload and facilitates reverse remodelling and functional recovery.
Merino D; Villar AV; García R; Tramullas M; Ruiz L; Ribas C; Cabezudo S; Nistal JF; Hurlé MA
Cardiovasc Res; 2016 Jun; 110(3):331-45. PubMed ID: 27068510
[TBL] [Abstract][Full Text] [Related]
7. Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine.
Hu X; Atzler D; Xu X; Zhang P; Guo H; Lu Z; Fassett J; Schwedhelm E; Böger RH; Bache RJ; Chen Y
Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1540-6. PubMed ID: 21493890
[TBL] [Abstract][Full Text] [Related]
8. Protein tyrosine phosphatase 1B inactivation limits aging-associated heart failure in mice.
Besnier M; Coquerel D; Favre J; Dumesnil A; Guerrot D; Remy-Jouet I; Mulder P; Djerada Z; Tamion F; Richard V; Ouvrard-Pascaud A
Am J Physiol Heart Circ Physiol; 2018 Jun; 314(6):H1279-H1288. PubMed ID: 29569957
[TBL] [Abstract][Full Text] [Related]
9. Blueberry anthocyanin‑enriched extract ameliorates transverse aortic constriction‑induced myocardial dysfunction via the DDAH1/ADMA/NO signaling pathway in mice.
Hu W; Wang W; Ma Q; Liu T; Zhang J; Zhang J
Mol Med Rep; 2020 Jan; 21(1):454-462. PubMed ID: 31746378
[TBL] [Abstract][Full Text] [Related]
10. Repetitive ischemia increases myocardial dimethylarginine dimethylaminohydrolase 1 expression.
Zhang P; Fassett JT; Zhu G; Li J; Hu X; Xu X; Chen Y; Bache RJ
Vasc Med; 2017 Jun; 22(3):179-188. PubMed ID: 28145161
[TBL] [Abstract][Full Text] [Related]
11. Effect of asymmetric dimethylarginine (ADMA) on heart failure development.
Liu X; Hou L; Xu D; Chen A; Yang L; Zhuang Y; Xu Y; Fassett JT; Chen Y
Nitric Oxide; 2016 Apr; 54():73-81. PubMed ID: 26923818
[TBL] [Abstract][Full Text] [Related]
12. Dimethylarginine dimethylaminohydrolase 1 modulates endothelial cell growth through nitric oxide and Akt.
Zhang P; Hu X; Xu X; Chen Y; Bache RJ
Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):890-7. PubMed ID: 21212404
[TBL] [Abstract][Full Text] [Related]
13. Dimethylarginine dimethylaminohydrolase-1 contributes to exercise-induced cardiac angiogenesis in mice.
Shi X; Luo X; Xu X
Biosci Trends; 2020 May; 14(2):115-122. PubMed ID: 32238672
[TBL] [Abstract][Full Text] [Related]
14. Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is frequently upregulated in prostate cancer, and its overexpression conveys tumor growth and angiogenesis by metabolizing asymmetric dimethylarginine (ADMA).
Reddy KRK; Dasari C; Duscharla D; Supriya B; Ram NS; Surekha MV; Kumar JM; Ummanni R
Angiogenesis; 2018 Feb; 21(1):79-94. PubMed ID: 29150732
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of DDAH2 Limits Pulmonary Hypertension and Right Ventricular Hypertrophy During Chronic Hypoxia in
Hannemann J; Glatzel A; Hillig J; Zummack J; Schumacher U; Lüneburg N; Harbaum L; Böger R
Front Physiol; 2020; 11():597559. PubMed ID: 33281630
[No Abstract] [Full Text] [Related]
16. Protective Roles of Interferon-γ in Cardiac Hypertrophy Induced by Sustained Pressure Overload.
Kimura A; Ishida Y; Furuta M; Nosaka M; Kuninaka Y; Taruya A; Mukaida N; Kondo T
J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29555642
[TBL] [Abstract][Full Text] [Related]
17. Dimethylarginine Dimethylaminohydrolase 1 Deficiency Induces the Epithelial to Mesenchymal Transition in Renal Proximal Tubular Epithelial Cells and Exacerbates Kidney Damage in Aged and Diabetic Mice.
Shi L; Zhao C; Wang H; Lei T; Liu S; Cao J; Lu Z
Antioxid Redox Signal; 2017 Dec; 27(16):1347-1360. PubMed ID: 28594240
[TBL] [Abstract][Full Text] [Related]
18. DDAH1 deficiency promotes intracellular oxidative stress and cell apoptosis via a miR-21-dependent pathway in mouse embryonic fibroblasts.
Zhao C; Li T; Han B; Yue W; Shi L; Wang H; Guo Y; Lu Z
Free Radic Biol Med; 2016 Mar; 92():50-60. PubMed ID: 26806551
[TBL] [Abstract][Full Text] [Related]
19. Interleukin enhancement binding factor 3 inhibits cardiac hypertrophy by targeting asymmetric dimethylarginine-nitric oxide.
Yang RH; Tan X; Ge LJ; Sun JC; Peng XD; Wang WZ
Nitric Oxide; 2019 Dec; 93():44-52. PubMed ID: 31536826
[TBL] [Abstract][Full Text] [Related]
20. Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation.
Donaldson C; Eder S; Baker C; Aronovitz MJ; Weiss AD; Hall-Porter M; Wang F; Ackerman A; Karas RH; Molkentin JD; Patten RD
Circ Res; 2009 Jan; 104(2):265-75, 11p following 275. PubMed ID: 19074476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
